New and updated preclinical data presented at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, by: Black Diamond Therapeutics, Exscientia, Flare Therapeutics, Ikena, Nuvalent, Ryvu, Scorpion, Theseus.